Organovo -4.2% after filing $190M mixed shelf

• Shortly after CEO Keith Murphy suggested another capital raise is on the way to help his company grow its R&D investments, Organovo (NASDAQ:ONVO) has filed to raise up to $190M via future stock, debt, and/or warrant offerings. (prospectus)
• The 3D-printed tissue developer had $50M in cash at the end of 2014, and no debt. Shares have fallen to $5.67 AH.